Literature DB >> 4118791

Endocrine profiles and breast cancer.

A E Argüelles, U L Poggi, C Saborida, C Hoffman, M Chekherdemian, O Blanchard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4118791     DOI： 10.1016/s0140-6736(73)90002-0

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

Review 1.  Complications of systemic oral contraceptive therapy: Neoplasm--breast, uterus, cervix and vagina.

Authors:  M A Sperling
Journal:  West J Med       Date:  1975-01

2.  A pilot study of urinary estrogen metabolites (16alpha-OHE1 and 2-OHE1) in postmenopausal women with and without breast cancer.

Authors:  G Ursin; S London; F Z Stanczyk; E Gentzschein; A Paganini-Hill; R K Ross; M C Pike
Journal:  Environ Health Perspect       Date:  1997-04       Impact factor: 9.031

3.  A prospective study of urinary oestrogen excretion and breast cancer risk.

Authors:  T J Key; D Y Wang; J B Brown; C Hermon; D S Allen; J W Moore; R D Bulbrook; I S Fentiman; M C Pike
Journal:  Br J Cancer       Date:  1996-06       Impact factor: 7.640

4.  Hormone levels in older women: a study of post-menopausal breast cancer patients and healthy population controls.

Authors:  L Bernstein; R K Ross; M C Pike; J B Brown; B E Henderson
Journal:  Br J Cancer       Date:  1990-02       Impact factor: 7.640

Review 5.  Estrogen replacement therapy (ERT) in high-risk cancer patients.

Authors:  K A Hutchinson-Williams; J N Gutmann
Journal:  Yale J Biol Med       Date:  1991 Nov-Dec

6.  Serum oestradiol-17 beta in women with benign and malignant breast disease.

Authors:  P C England; L G Skinner; K M Cottrell; R A Sellwood
Journal:  Br J Cancer       Date:  1974-12       Impact factor: 7.640
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.